Form 4: Lemaitre Vascular Director Jasinski Acquires Dividend Equivalent Rights

Director Lawrence J. Jasinski acquired dividend equivalent rights related to restricted stock unit and performance stock unit awards.

Summary

• On May 30, 2024, Lawrence J. Jasinski, a director of Lemaitre Vascular Inc. [LMAT], acquired dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit (RSU) and performance stock unit (PSU) awards.
• The acquisitions include 0.402 rights related to a 2021 RSU award, 0.8146 rights related to a 2022 RSU award, 0.8146 rights related to a 2022 PSU award, and 1.0426 rights related to a 2023 RSU award.
• Each dividend equivalent right is the economic equivalent of one share of Lemaitre Vascular's common stock and vests proportionately with the underlying award.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing the acquisition of dividend equivalent rights, which is neither particularly positive nor negative. It reflects standard compensation practices.

Positives

• The acquisition of dividend equivalent rights suggests continued alignment of the director's interests with those of the shareholders.
• The vesting of these rights is tied to the vesting of the underlying RSU and PSU awards, incentivizing long-term performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of dividend equivalent rights aligns the director's interests with those of shareholders, as the rights vest proportionately with the underlying equity awards.

Key Dates